Zhongze Therapeutics
PrivateLast Round
Pre Seed
Sep 30, 2021
Total Funding Raised
$10M
Company Overview
Zhongze Therapeutics operates in Healthcare & Life Sciences and is based in Shanghai. Its latest recorded funding round was a Pre Seed round in September 2021.
Zhongze Therapeutics is a clinical-stage biotechnology company that focuses on the discovery, development, and commercialization of innovative therapies for psychiatric and neurological disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Mental Health, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Zhongze Therapeutics Comparables
Compare Zhongze Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Viage Therapeutics | 80% | |
| NeuShen Therapeutics | 79% | |
| Neurosterix | 78% |
For institutional investors. Book with your work email.
Zhongze Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Zhongze Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cenova Capital | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 30, 2021
$10M round led by Cenova Capital
For institutional investors. Book with your work email.
Zhongze Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Zhongze Therapeutics's valuation, stock price, and market status.
Is Zhongze Therapeutics a public or private company?
Zhongze Therapeutics is a private company.
What is the current stock price of Zhongze Therapeutics?
Zhongze Therapeutics is a private company, so its shares have no public market price. Caplight tracks Zhongze Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Zhongze Therapeutics worth (valuation)?
Valuation information for Zhongze Therapeutics is not publicly available.
Can I buy Zhongze Therapeutics stock?
Zhongze Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Zhongze Therapeutics's last funding round?
Zhongze Therapeutics's most recent funding round was Pre Seed on September 30, 2021.
Who are the main investors in Zhongze Therapeutics?
Key investors in Zhongze Therapeutics include Cenova Capital.
Will Zhongze Therapeutics IPO soon?
No public IPO plans have been announced for Zhongze Therapeutics.
How can I track Zhongze Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Zhongze Therapeutics's shares on secondary markets.